Use of Smartphone-Based Video Directly Observed Therapy to Increase Tuberculosis Medication Adherence: An Interventional Study.

MDR-TB Medication Adherence Saudi Arabia Smartphone Tuberculosis VDOT

Journal

Galen medical journal
ISSN: 2322-2379
Titre abrégé: Galen Med J
Pays: Iran
ID NLM: 101625418

Informations de publication

Date de publication:
2023
Historique:
received: 25 05 2023
revised: 06 06 2023
accepted: 13 06 2023
medline: 3 7 2023
pubmed: 3 7 2023
entrez: 28 10 2024
Statut: epublish

Résumé

Tuberculosis (TB) treatment through Directly Observed Therapy (DOT) has an alternative form of video surveillance therapy (VOT) that utilizes the technological capabilities of smartphones to provide patients with low-cost access to doctors without impacting their work and personal life. We aimed to assess TB patients' drug compliance, perceptions, and feasibility towards smartphone-based video direct observed therapy (VDOT) in Jeddah, KSA. We conducted a prospective non-randomized interventional study. We delivered smartphone-based VDOT among previously unstudied patients to monitor adherence to the treatment regimen. The expected total number of VDOT sessions was1200. We conducted post-intervention interviews to assess acceptability and satisfaction. In this study, we included 20 participants, 16 of whom were males, with a mean age of 34.3 (±12.5) years. No side effects to the treatments were identified in all participants. The adherence rate for the total period was 93% and 99.5%, measured by the first and second methods, respectively. Most participants were satisfied with the VDOT experience, the time spent on sessions, and the approach's privacy. This study provides promising results for the feasibility and effectiveness of smartphone-based VDOT for TB treatment to increase adherence which was indicated by a high compliance rate, acceptability, and high satisfaction level.

Sections du résumé

BACKGROUND BACKGROUND
Tuberculosis (TB) treatment through Directly Observed Therapy (DOT) has an alternative form of video surveillance therapy (VOT) that utilizes the technological capabilities of smartphones to provide patients with low-cost access to doctors without impacting their work and personal life. We aimed to assess TB patients' drug compliance, perceptions, and feasibility towards smartphone-based video direct observed therapy (VDOT) in Jeddah, KSA.
MATERIALS AND METHODS METHODS
We conducted a prospective non-randomized interventional study. We delivered smartphone-based VDOT among previously unstudied patients to monitor adherence to the treatment regimen. The expected total number of VDOT sessions was1200. We conducted post-intervention interviews to assess acceptability and satisfaction.
RESULTS RESULTS
In this study, we included 20 participants, 16 of whom were males, with a mean age of 34.3 (±12.5) years. No side effects to the treatments were identified in all participants. The adherence rate for the total period was 93% and 99.5%, measured by the first and second methods, respectively. Most participants were satisfied with the VDOT experience, the time spent on sessions, and the approach's privacy.
CONCLUSION CONCLUSIONS
This study provides promising results for the feasibility and effectiveness of smartphone-based VDOT for TB treatment to increase adherence which was indicated by a high compliance rate, acceptability, and high satisfaction level.

Identifiants

pubmed: 39464537
doi: 10.31661/gmj.v12i.3067
pmc: PMC11512422
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-8

Informations de copyright

Copyright© 2023, Galen Medical Journal.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Manal M Al Daajani (M)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Abdullah J Alsahafi (A)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Abdullah M Algarni (A)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Abdulhamed L Moawwad (A)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Ahmed A Osman (A)

Faculty of Medicine, Kassala University, Kassala, Sudan.

Khalid Y A Algaali (K)

Public Health Operations Center, Ministry of Health, Riyadh, KSA.

Mohammed Abdalaziz (M)

Infection Prevention and Control Department, King Abdulaziz Medical City Ministry of National Guard, Jeddah, KSA.

Muhammad A Halwani (M)

Department of Microbiology, Faculty of Medicine, Al Baha University, Al Baha, KSA.

Shrooq M Aldajani (S)

Department of Oral and Maxillofacial Sciences, Vision (Al-Farabi) Colleges for Dentistry and Nursing, Jeddah, KSA.

Nazik M H Mohammed (N)

Faculty of Public Health and Health Informatics, Umm Al-Qura University, Makkah, KSA.

Heassah S Alshamrani (H)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Mohammed N Alshahrani (M)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Ghadah M Albostani (G)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Naif G Alshammari (N)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Rami S Alzahrani (R)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Saadiya O Alsomali (S)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Ibrahim Assiri (I)

Public Health Department, Jeddah Health Affairs, Kingdom of Saudi Arabia (KSA).

Classifications MeSH